Back
Royal Bank of Canada Vs. Novartis AG Industry Stock Comparison
Buy
64
RY
Royal Bank of Canada
Last Price:
$116.27
Seasonality Move:
2.92%
Buy
70
NVSEF
Novartis AG
Last Price:
$107.55
Seasonality Move:
6.56%
Buy
64
Royal Bank of Canada (RY)
is a Buy
Is Royal Bank of Canada a Buy, Sell or Hold?
-
The current Royal Bank of Canada [RY] share price is $116.65. The Score for RY is 64, which is 28% above its historic median score of 50, and infers lower risk than normal.
-
RY is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
70
Novartis AG (NVSEF)
is a Buy
Is Novartis AG a Buy, Sell or Hold?
-
The current Novartis AG [NVSEF] share price is $116.60. The Score for NVSEF is 70, which is 40% above its historic median score of 50, and infers lower risk than normal.
-
NVSEF is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
RY Stock Price Chart
What is Royal Bank of Canada's stock price today?
-
The Royal Bank of Canada share price today is $116.65The current trend is relatively stagnant and RY is experiencing slight selling pressure.
NVSEF Stock Price Chart
What is Novartis AG's stock price today?
-
The Novartis AG share price today is $116.60Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NVSEF is experiencing slight buying pressure.
RY Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -1.04 | Sell |
Relative Strength Index (14 RSI): | 53.95 | Buy |
Chaikin Money Flow: | -68149 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (112.12 - 118.78) | Buy |
Bollinger Bands (100): | (116.59 - 124.43) | Sell |
NVSEF Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 2.09 | Buy |
Relative Strength Index (14 RSI): | 61.26 | Buy |
Chaikin Money Flow: | 0 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (107.28 - 114.3) | Buy |
Bollinger Bands (100): | (98.5 - 109.54) | Buy |
RY Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 113.86 | Buy |
20-day SMA: | 114.37 | Buy |
50-day SMA: | 117.89 | Sell |
200-day SMA: | 117.54 | Sell |
8-day EMA: | 114.44 | Buy |
20-day EMA: | 114.82 | Buy |
50-day EMA: | 117.12 | Sell |
200-day EMA: | 115.88 | Buy |
NVSEF Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 111.91 | Buy |
20-day SMA: | 111.76 | Buy |
50-day SMA: | 106.31 | Buy |
200-day SMA: | 106.86 | Buy |
8-day EMA: | 113.26 | Buy |
20-day EMA: | 111.23 | Buy |
50-day EMA: | 107.91 | Buy |
200-day EMA: | 104.85 | Buy |
Royal Bank of Canada Earnings Growth & RY Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.14 per share, an increase next quarter of $0.13 per share, an increase this year of $0.88 per share, and an increase next year of $0.66 per share.
Novartis AG Earnings Growth & NVSEF Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Royal Bank of Canada Technical Analysis
Mar 12 | Mar 13 | Mar 14 | Mar 17 | Mar 18 | Mar 19 | Mar 20 | Mar 21 | Mar 24 | Mar 25 | |
---|---|---|---|---|---|---|---|---|---|---|
Mar | ||||||||||
12 | 13 | 14 | 17 | 18 | 19 | 20 | 21 | 24 | 25 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Novartis AG Technical Analysis
Mar 12 | Mar 13 | Mar 14 | Mar 17 | Mar 18 | Mar 19 | Mar 20 | Mar 21 | Mar 24 | Mar 25 | |
---|---|---|---|---|---|---|---|---|---|---|
Mar | ||||||||||
12 | 13 | 14 | 17 | 18 | 19 | 20 | 21 | 24 | 25 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |